Significant findings
Of the SLE patients, 28% had anti-C1q antibody (Ab), 84% of whom had active renal disease (compared to 13% of anti-C1q negative patients), and the Ab was predominantly IgG2. Fc?RIIA genotyping showed that although allele frequencies were similar in patients and controls, in patients with anti-C1q there was an increased frequency of the R131 allele (70% cf 55% normals, p < 0.01). SLE patients with nephritis also expressed this allele more frequently (68%, p = 0.01). R131 homozygotes were as common in SLE as in normal controls (~33%) but significantly more common in patients with anti-C1q (50%, p = 0.01) or nephritis (48%, p = 0.009). 
Comments

This paper provides an interesting insight into the pathogenesis of SLE. The corollary, that
Methods
IgG subclasses, anti-C1q(CLR) antibodies (including IgG subclass-specific anti-C1q) and Fc?RIIA genotypes were analysed in 195 caucasoid SLE patients and 283 caucasoid normal controls.
Additional information
A paper in the same issue (Dijstelbloem HM et al, Arth Rheum 1999; 42: 1823-1827)(abstract) examines FcR polymorphisms in Wegener's granulomatosis. Although there was no significant association between individual FcR genotype and disease susceptibility, individuals who were RIIA H131/H131 together with RIIa V158/V158 were significantly more common in Wegener's granulomatosis (p = 0.0092). This genotype was associated with an 83% 5-year relapse rate (cf 32%, p < 0.01).
